Smartphone-Driven Augmented Reality Headset for Low-Light Mobility Assistance in Retinitis Pigmentosa.

IF 4.2 1区 医学 Q1 OPHTHALMOLOGY
Giovanni Rubegni,Paolo Ferri,Emanuele Mocciardini,Luca Mapelli,Gaetano Savaresi,Rebecca Prandini,Leonardo Colombo,Alessandra Cartocci,Gian Marco Tosi,Luca Rossetti
{"title":"Smartphone-Driven Augmented Reality Headset for Low-Light Mobility Assistance in Retinitis Pigmentosa.","authors":"Giovanni Rubegni,Paolo Ferri,Emanuele Mocciardini,Luca Mapelli,Gaetano Savaresi,Rebecca Prandini,Leonardo Colombo,Alessandra Cartocci,Gian Marco Tosi,Luca Rossetti","doi":"10.1016/j.ajo.2025.09.048","DOIUrl":null,"url":null,"abstract":"PURPOSE\r\nTo evaluate the effectiveness of a smartphone-driven augmented reality (AR) headset in expanding the functional visual field and improving mobility performance under low-light conditions in patients with retinitis pigmentosa (RP).\r\n\r\nDESIGN\r\nProspective, single-center before-and after study.\r\n\r\nSUBJECTS\r\nThirty-two patients (18 females, 14 males; median age: 55.5 years) with genetically confirmed typical RP, a binocular uncorrected distance visual acuity (BUVA) of ≥20/200, and VF restricted to <10° in both eyes.\r\n\r\nMETHODS\r\nParticipants were assessed at baseline and under AR-assisted conditions. The AR system consisted of XREAL One glasses paired with an iPhone 15. Visual function was evaluated through ETDRS visual acuity, Pelli-Robson contrast sensitivity, and tangent screen perimetry. Functional mobility was assessed using the Multi-Luminance Mobility Test (MLMT). Data were analyzed using paired t-tests and Wilcoxon signed-rank tests.\r\n\r\nMAIN OUTCOME MEASURES\r\nThe primary outcome was the change in MLMT score, secondary outcomes included changes in binocular visual field area, contrast sensitivity, and uncorrected binocular visual acuity (BUVA) with and without the AR device.\r\n\r\nRESULTS\r\nUse of the AR headset resulted in a ∼3.4-fold enlargement in binocular VF (p < 0.001) and a median improvement of 3 points in MLMT score (from median 3 to 6; p < 0.001). The proportion of patients able to complete the MLMT at 1 lux increased from 0% to 88%. While standard minification mode reduced BUVA by 0.58 logMAR (p < 0.001), the 4× mode maintained baseline acuity (p = 0.166) and improved contrast sensitivity (p < 0.001).\r\n\r\nCONCLUSIONS\r\nThis study demonstrates that a consumer-grade AR headset combined with a smartphone can deliver substantial improvements in low-light mobility and visual field function for RP patients, offering a scalable and affordable alternative to conventional low-vision aids. These findings highlight the potential of leveraging consumer technologies for accessible, patient-centered visual rehabilitation.","PeriodicalId":7568,"journal":{"name":"American Journal of Ophthalmology","volume":"108 1","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajo.2025.09.048","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

PURPOSE To evaluate the effectiveness of a smartphone-driven augmented reality (AR) headset in expanding the functional visual field and improving mobility performance under low-light conditions in patients with retinitis pigmentosa (RP). DESIGN Prospective, single-center before-and after study. SUBJECTS Thirty-two patients (18 females, 14 males; median age: 55.5 years) with genetically confirmed typical RP, a binocular uncorrected distance visual acuity (BUVA) of ≥20/200, and VF restricted to <10° in both eyes. METHODS Participants were assessed at baseline and under AR-assisted conditions. The AR system consisted of XREAL One glasses paired with an iPhone 15. Visual function was evaluated through ETDRS visual acuity, Pelli-Robson contrast sensitivity, and tangent screen perimetry. Functional mobility was assessed using the Multi-Luminance Mobility Test (MLMT). Data were analyzed using paired t-tests and Wilcoxon signed-rank tests. MAIN OUTCOME MEASURES The primary outcome was the change in MLMT score, secondary outcomes included changes in binocular visual field area, contrast sensitivity, and uncorrected binocular visual acuity (BUVA) with and without the AR device. RESULTS Use of the AR headset resulted in a ∼3.4-fold enlargement in binocular VF (p < 0.001) and a median improvement of 3 points in MLMT score (from median 3 to 6; p < 0.001). The proportion of patients able to complete the MLMT at 1 lux increased from 0% to 88%. While standard minification mode reduced BUVA by 0.58 logMAR (p < 0.001), the 4× mode maintained baseline acuity (p = 0.166) and improved contrast sensitivity (p < 0.001). CONCLUSIONS This study demonstrates that a consumer-grade AR headset combined with a smartphone can deliver substantial improvements in low-light mobility and visual field function for RP patients, offering a scalable and affordable alternative to conventional low-vision aids. These findings highlight the potential of leveraging consumer technologies for accessible, patient-centered visual rehabilitation.
智能手机驱动的增强现实耳机用于色素性视网膜炎的弱光行动辅助。
目的评价智能手机驱动的增强现实(AR)头戴设备在低光条件下扩大色素性视网膜炎(RP)患者的功能性视野和改善活动能力的有效性。前瞻性,单中心研究前后。受试者32例(女性18例,男性14例,中位年龄55.5岁)遗传确诊为典型RP,双眼未矫正距离视力(BUVA)≥20/200,双眼视距限制在<10°。方法在基线和ar辅助条件下对参与者进行评估。增强现实系统包括XREAL One眼镜和iPhone 15。通过ETDRS视敏度、Pelli-Robson对比敏感度和切线屏幕视野评估视觉功能。使用多亮度迁移率测试(MLMT)评估功能迁移率。数据分析采用配对t检验和Wilcoxon符号秩检验。主要观察指标:主要观察指标是MLMT评分的变化,次要观察指标包括双眼视野面积、对比敏感度和未矫正双眼视力(BUVA)的变化。结果AR头戴设备的使用导致双眼VF增大~ 3.4倍(p < 0.001), MLMT评分中位数提高3分(中位数从3分提高到6分;p < 0.001)。能够在1勒克斯完成MLMT的患者比例从0%增加到88%。虽然标准缩小模式降低了0.58 logMAR的BUVA (p < 0.001),但4×模式保持了基线视力(p = 0.166)并提高了对比灵敏度(p < 0.001)。本研究表明,结合智能手机的消费级AR头显可以显著改善RP患者在弱光下的行动能力和视野功能,为传统的低视力辅助设备提供可扩展且经济实惠的替代方案。这些发现突出了利用消费者技术实现可获得的、以患者为中心的视觉康复的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
9.20
自引率
7.10%
发文量
406
审稿时长
36 days
期刊介绍: The American Journal of Ophthalmology is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and visual science specialists describing clinical investigations, clinical observations, and clinically relevant laboratory investigations. Published monthly since 1884, the full text of the American Journal of Ophthalmology and supplementary material are also presented online at www.AJO.com and on ScienceDirect. The American Journal of Ophthalmology publishes Full-Length Articles, Perspectives, Editorials, Correspondences, Books Reports and Announcements. Brief Reports and Case Reports are no longer published. We recommend submitting Brief Reports and Case Reports to our companion publication, the American Journal of Ophthalmology Case Reports. Manuscripts are accepted with the understanding that they have not been and will not be published elsewhere substantially in any format, and that there are no ethical problems with the content or data collection. Authors may be requested to produce the data upon which the manuscript is based and to answer expeditiously any questions about the manuscript or its authors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信